Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy (Q61657695)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 March 2007

Language	Label	Description	Also known as
English	Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy	scientific article published on 15 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

based on heuristic

inferred from title

myeloid leukemia

1 reference

based on heuristic

inferred from title

chronic myeloid leukemia

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Francesco Dazzi

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Simula MP

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marktel S

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Fozza C

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kaeda J

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nadal E

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bua M

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Rahemtulla A

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kanfer E

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marin D

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Olavarria E

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Goldman JM

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Apperley JF

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

15 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

943-948

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361226%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404641

0 references

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404641

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61657695&oldid=2122275929"